Our round-up of biotech financings is led this week by Braveheart Bio, a San Francisco biotech that has launched with $185 million, a lead drug for hypertrophic cardiomyopathy (HCM), and Biogen CEO ...
A celebrated ’90s crime classic returns to Paramount+ and reclaims its place as one of the decade’s most iconic and enduring ...
As we enter the second week of December, the past few weeks have been filled with blockbusters and independent films for audiences to discover. From holiday remakes to political dramedies, this season ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback